1.Molecular epidemiology of G6PD deficiency in Chaozhou area of eastern Guangdong Province.
Fen LIN ; Jiaoren WU ; Hui YANG ; Min LIN ; Liye YANG
Chinese Journal of Medical Genetics 2016;33(1):26-29
OBJECTIVETo determine the incidence and molecular characteristics of G6PD deficiency in Chaozhou region of eastern Guangdong Province.
METHODSG6PD enzyme activity was assayed with an auto-bioanalyzer. Reverse dot blotting (RDB) was used for detecting 6 common G6PD mutations. Samples with no mutation detected by RDB were further sequenced for unknown mutations.
RESULTSThe rate of G6PD deficiency was 3.36% (142/4224). 2.33% (47/2013) of males and 4.3% (95/2208) of females were affected. 12 mutations were detected among the 142 patients, which included c.1376G>T, c.1388G>A, c.1024C>T, c.392G>T, c.871G>A, c.95A>G, c.517T>C, c.131C>G, c.1376G>T/c.517T>C, c.871G>A/IVS-1193T>C/c.1311C>T, c.1376G>T/IVS-11, 93T>C/c.1311C>T and c.1376G>T/c.486_34delT (rs3216174).
CONCLUSIONThe incidence of G6PD deficiency in Chaozhou region was lower than that of the Hakka population of Guangdong Province, and the mutation types were diversely distributed in this region. c.1376G>T, c.1388G>A and c.1024C>T were the most common mutations, which was followed by c.517T>C. In addition, c.131C>G has been first discovered in the Chinese population. c.1376G>T/c.517T>C and c.1376G>T/c.486_34delT(rs3216174) were new types of compound heterozygous mutations in females.
Adolescent ; Base Sequence ; China ; epidemiology ; ethnology ; Female ; Genotype ; Glucosephosphate Dehydrogenase ; genetics ; Glucosephosphate Dehydrogenase Deficiency ; enzymology ; epidemiology ; ethnology ; genetics ; Humans ; Incidence ; Male ; Molecular Epidemiology ; Molecular Sequence Data ; Mutation
2.Novel mutations p.Lys327X and p.Leu424CysfsX8 underlying congenital factor Ⅺ deficiency.
Miaoshan WENG ; Fen LIN ; Jincan ZHANG ; Jiaoren WU ; Shaoyi XING ; Liye YANG
Chinese Journal of Medical Genetics 2019;36(8):801-804
OBJECTIVE:
To analyze the phenotype and genetic mutations in a pedigree affected with factor Ⅺ (FⅪ) deficiency.
METHODS:
Activated partial thromboplastin time (APTT), FⅪ activity (FⅪ:C) and FⅪ antigen (FⅪ:Ag) were determined for the proband and his family members. All exons and exon-intron boundaries of the FⅪ gene of the proband were analyzed by direct sequencing. Suspected mutation was verified in his family members.
RESULTS:
The proband had APTT of 82.4 s, FⅪ:C of 0.8%, and FⅪ:Ag of <1%. DNA sequencing showed that he has carried c.1033A>T (Lys327X) mutation in exon 10 and c.1325delT (Leu424CysfsX8) mutation in exon 12 of the FⅪ gene. His elder sister, son, daughter, two granddaughters and one grandson were heterozygous carriers of the c.1033A>T mutation, while his older sister and younger brother were heteozygous carriers of the c.1325delT mutation. Analysis using Mutation Taster software showed that both p.Lys327X and p.Leu424CysfsX8 may affect the function of protein and lead to the corresponding disease.
CONCLUSION
The novel mutations of Lys327X and Leu424CysfsX8 of the the FⅪ gene probably underlie the pathogenesis of congenital coagulation factor Ⅺ deficiency in this pedigree.
Exons
;
Factor XI
;
genetics
;
Factor XI Deficiency
;
genetics
;
Female
;
Heterozygote
;
Humans
;
Male
;
Mutation
;
Pedigree